Trial Profile
Atorvastatin versus rosuvastatin in hypercholesterolaemic patients with or without the 3'UTR/lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) polymorphism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2011
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 22 Mar 2011 New trial record